Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | HDAC1 | Q13547 | 14/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 14/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 13/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 13/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 12/20 | 0.41 |
| ▸ | HDAC7 | Q8WUI4 | 12/20 | 0.41 |
| ▸ | HDAC9 | Q9UKV0 | 12/20 | 0.41 |
| ▸ | HDAC5 | Q9UQL6 | 12/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 12/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 12/20 | 0.41 |
| ▸ | HDAC10 | Q969S8 | 12/20 | 0.41 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | BRD4 | O60885 | 1/20 | 0.38 |
| ▸ | NCOR1 | O75376 | 1/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodipamide SCHEMBL29606858 | 1.00 | TSHR (1.00) | TSHRMAPK1HDAC1HDAC6HDAC11 | |
| Iodipamide SCHEMBL1860819 | 0.98 | TSHR (0.97) | TSHRMAPK1HDAC1HDAC6HDAC11 | |
| Iodipamide SCHEMBL8816246 | 0.93 | TSHR (0.86) | TSHRMAPK1HDAC1HDAC6HDAC11 | |
| Iodipamide SCHEMBL10620456 | 0.92 | TSHR (0.84) | TSHRMAPK1HDAC1HDAC6HDAC11 | |
| SCHEMBL12143826 | 0.89 | TSHR (0.80) | TSHRMAPK1HDAC1HDAC6HDAC11 | |
| SCHEMBL29204744 | 0.88 | MAPK1 (0.78) | TSHRMAPK1HDAC1HDAC6HDAC11 | |
| SCHEMBL8212411 | 0.87 | TSHR (0.76) | TSHRMAPK1HDAC1HDAC6HDAC11 | |
| Iotranic Acid SCHEMBL2109613 | 0.85 | TSHR (0.74) | TSHRMAPK1CYP3A4MEN1POLB | |
| Iodoxamic Acid SCHEMBL29397252 | 0.85 | TSHR (0.74) | TSHRMAPK1CYP3A4MEN1POLB | |
| Iodoxamic Acid SCHEMBL377402 | 0.85 | TSHR (0.74) | TSHRMAPK1CYP3A4MEN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2396 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132404-A1 | MODIFIED OLIGONUCLEOTIDES AND DOUBLE-STRANDED RNAS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2026-05-14 | — | — | US | claimed |
| EP-4561631-A2 | MODIFIED OLIGONUCLEOTIDES AND DOUBLE-STRANDED RNAS | Alnylam Pharmaceuticals, Inc. (US) | 2025-06-04 | — | — | EP | claimed |
| US-20250170280-A1 | LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE, PREPARATION METHOD THEREFOR, AND USES THEREOF | BEIJING INNO MEDICINE CO., LTD. (CN) | 2025-05-29 | — | — | US | claimed |
| US-20250170279-A1 | LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE, PREPARATION METHOD THEREFOR, AND USES THEREOF | BEIJING INNO MEDICINE CO., LTD. (CN) | 2025-05-29 | — | — | US | claimed |
| US-12269021-B2 | Artificial protein catalyst | GLYTECH, INC. (JP) | 2025-04-08 | — | — | US | claimed |
| WO-2024176961-A1 | PROTEIN RECOGNIZING K-Ras GENE MUTATION CANCER | 国立研究開発法人理化学研究所 | 2024-08-29 | — | — | WO | claimed |
| WO-2024073709-A2 | MODIFIED OLIGONUCLEOTIDES AND DOUBLE-STRANDED RNAS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2024-04-04 | — | — | WO | claimed |
| CN-115245411-A | Adjustable vascular stent with different developing areas | 张敏 | 2022-10-28 | — | — | CN | claimed |
| US-20220241765-A1 | NOVEL ARTIFICIAL PROTEIN CATALYST | GLYTECH, INC. (JP) | 2022-08-04 | — | — | US | claimed |
| EP-3978023-A1 | NOVEL ARTIFICIAL PROTEIN CATALYST | Glytech, Inc. (JP) | 2022-04-06 | — | — | EP | claimed |
| US-5264610-A | X-ray contrast agents | STERLING WINTHROP INC. (US) | 1993-11-23 | — | — | US | claimed |
| US-5260478-A | Contrast agents in x-ray imaging compositions; medical diagnosis | STERLING WINTHROP INC. (US) | 1993-11-09 | — | — | US | claimed |
| CN-1074378-A | Radiophotography is with contrast agent and contrast compositions and utilize the radiological imaging method of this type of medicament | GUERBET SA (FR) | 1993-07-21 | — | — | CN | claimed |
| EP-0510086-A4 | INTERDIGITATION-FUSION LIPOSOMES AND GELS | — | 1993-03-17 | — | — | EP | claimed |
| EP-0510086-A1 | INTERDIGITATION-FUSION LIPOSOMES AND GELS. | LIPOSOME CO INC (US) | 1992-10-28 | — | — | EP | claimed |
| EP-0498482-A2 | X-ray contrast compositions useful in medical imaging | NanoSystems L.L.C. (US) | 1992-08-12 | — | — | EP | claimed |
| EP-0274467-B1 | HEPATOCYTE DIRECTED VESICLE DELIVERY SYSTEM | GEHO, W., Blair (US) | 1992-05-20 | — | — | EP | claimed |
| CN-1061155-A | The preparation method of injection embolism medicament for birth control with reducibility | ZHAO SHENGCAI (CN) | 1992-05-20 | — | — | CN | claimed |
| WO-1991010422-A1 | INTERDIGITATION-FUSION LIPOSOMES AND GELS | THE LIPOSOME COMPANY, INC. (US) | 1991-07-25 | — | — | WO | claimed |
| EP-0050457-A1 | Radiopaque cyanoacrylate compositions | BioNexus, Inc. (US) | 1982-04-28 | — | — | EP | claimed |